Millennium Pushing Ahead With Velcade In Non-Hodgkins Lymphoma
This article was originally published in The Pink Sheet Daily
Executive Summary
NHL population represents a greater opportunity than all multiple myeloma settings combined, CEO Dunsire says during business update.